IHS Chemical Week

Markets :: Fine Chemicals/Biotech :: Pharmaceutical ingredients

Pharma/fine chemicals roundup—2 July 2013

3:53 AM MDT | July 2, 2013 | Deepti Ramesh

Aspen acquires Merck & Co. API plants and 11 finished-dosage products for $1 billion Aspen (Durban, South Africa), the ninth-largest generic pharmaceutical company in the world, says it has signed an agreement with Merck & Co. (Whitehouse Station, NJ), which is called MSD outside the United States and Canada, for the acquisition of an active pharmaceutical ingredient (API) manufacturing business, which is located in the Netherlands with a satellite facility and sales office in the United States. The API business manufactures for MSD and the market...

This information is only available to Chemical Week subscribers.


Forgot your user ID or password?
Click here to have it sent to you.

Not an IHS Chemical Week subscriber yet?

Here's why you should be:

  • 31 issues of Chemical Week magazine a year in print or digital format
  • Real time news and analysis on chemweek.com 
  • 20+ years of online archives
  • Topical e-newsletters that capture the most impactful events
  • Special issues with a regional or company focus
  • Global Outlook issue

Subscribe now


Comments (1) for Pharma/fine chemicals roundup—2 July 2013
i enjoyed reading your blog. another knowledge for me <a href="http://www.austinwholesaledecking.com/ipe.htm">Ipe Decking</a>
Posted by krystal on Tuesday, July 2, 2013 @ 09:46 AM

contact us | about us | privacy policy | sitemap

ihsCopyright © IHS, Inc.All rights reserved.Reproduction in whole or in part without permission is prohibited.

North Asia Russia Southeast Asia China India/Pakistan Middle East Eastern Europe Western Europe Central America Canada USA Australia/New Zealand South America Africa